CAMP4 Therapeutics Corporation (CAMP) has a consensus analyst rating of Buy, based on 24 analysts covering the stock. Of those, 16 recommend buying, 7 recommend holding, and 1 recommend selling.
The analyst consensus price target for CAMP is $11.40, representing a +152.2% upside from the current price of $4.52. Price targets range from a low of $5.00 to a high of $18.00.
